A Turning Point for AI Patent Eligibility?

Published October 2025

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case

In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial and Appeal Board (PTAB) decision that had introduced a new § 101 rejection against a DeepMind patent application on machine-learning methods (Ex parte Desjardins, Appeal 2024-000567, App. 16/319,040). The decision, issued through the Appeals Review Panel (ARP), signals a possible policy shift in how the USPTO approaches patent eligibility for AI-related inventions. Full decision: USPTO PDF (Sept 26 2025)

The case

The DeepMind application concerned techniques for sequentially training machine-learning models to improve efficiency and reduce “catastrophic forgetting.” While the examiner had rejected the claims under § 103 for obviousness, the PTAB went further, adding a new § 101 rejection sua ponte, finding the claims to be directed to an abstract mathematical algorithm without a practical application.

On review of the PTAB’s decision, the ARP (Director Squires, Acting Commissioner for Patents Wallace, and Vice Chief Judge Kim) vacated the new § 101 ground, finding the PTAB’s reasoning “overbroad.” While acknowledging that the claims included mathematical concepts, the panel held that the invention as a whole integrated the abstract idea into a practical application, improving how a computer (here, a machine-learning system) functions. The ARP highlighted concrete benefits such as reduced storage needs and improved computational efficiency, invoking Enfish v. Microsoft to confirm that software improving computer functionality can be patent-eligible.

Director Squires further emphasized that §§ 102, 103 and 112, not § 101, should serve as the primary gatekeepers of patentability. He warned against categorically treating AI or machine-learning inventions as inherently abstract, noting that doing so risks undermining U.S. technological leadership.

The Context: USC §101 and the Mayo/Alice Framework

For more than a decade, USC §101 patent eligibility for software and AI has been governed by the Mayo/Alice test initially laid out by the Supreme Court, which asks:

  1. Is the claim directed to a judicial exception (law of nature, natural phenomenon, abstract idea) devoid of practical application? (this is referred to as “Step 2A” in the USPTO’s MPEP, see [MPEP 2106])
  2. If so, does it include an inventive concept – elements that amount to “significantly more” than the exception, transforming the idea into patent-eligible subject matter? (Known as “Step 2B” in the MPEP)

Under this framework, many AI and data-processing claims have been deemed abstract, often reduced to a “mathematical algorithm performed on a generic computer.” PTAB panels and examiners have applied this test inconsistently, sometimes dismissing genuine technical improvements as mere automation.

Squires’ intervention reflects growing frustration, shared by industry and parts of the judiciary, that § 101 has become an overly subjective barrier to protecting genuine software innovation. In particular, the ARP criticizes the PTAB’s reasoning of equating “any machine learning” with an ineligible algorithm, and demands that panels and examiners properly engage precedent like Enfish [Enfish, LLC v. Microsoft Corp., 822 F.3d 1327, 1339 (Fed. Cir. 2016)] which already recognized that “[m]uch of the advancement made in computer technology consists of improvements to software that, by their very nature, may not be defined by particular physical features but rather by logical structures and processes”.

The ARP’s decision aligns with recent USPTO guidance encouraging examiners to recognize technological improvements described in the specification as part of the “practical-application” analysis. See also USPTO Eligibility Guidance 2024 Update.

The European view

Interestingly, the corresponding European patent of the DeepMind patent family was granted by the EPO (EP3485432B1). During prosecution, following the standard approach in Europe, the EPO first considered that the training method per se was a non-technical mathematical method but that its implementation on a computer conferred a technical character to the invention making it de facto patent-eligible subject-matter.

However, after acknowledging the novelty and potential inventive step of the method, the EPO considered the existence of an inventive technical effect applied to the training method in terms of its integration into a practical application, noting in particular that: “the claim should be formulated in a way that the technical effect is clearly defined [and] directed to a real world task in which the mathematical method serves […] a technical purpose.”

Notably, the granted claim comprises additional features reciting, inter alia: “The machine learning model generates the output based on the received input image […] wherein the […] machine learning tasks comprise different image recognition tasks [requiring] the recognition of different object or pattern in an image provided to the machine learning model to generate an […] output”.

An alignment with European patent law?

Unlike the conventional approach of the USPTO, the European Patent Office applies a “technical character / technical effect” approach rather than an abstract-idea test. While “mathematical methods” and “computer programs as such” are excluded under Art. 52 EPC, an invention that produces a further technical effect, for instance, improving a processor or optimizing resource use, may be patentable. See EPO Guidelines G-II 3.3.1 (2025).

Thus, whereas the US often filters claims at the eligibility stage, the EPO typically proceeds to inventive-step analysis once technical character is established. The EPO framework is perhaps more rigorously structured, the main question being whether the claimed contribution is technical.

Therefore, the recent ARP decision moves the USPTO slightly closer to the European model by emphasising technological context over categorical exclusion.

Why the Decision Matters
  • Recognition of AI as a Technical Field

The ARP acknowledged that innovations in model architecture or training methods can constitute technological improvements, not just abstract mathematics. This aligns AI closer to other computer-implemented technologies (e.g., database management or data-storage design) which courts have found to be patent eligible.

  • Strategic Policy Implications

This move fits within broader U.S. policy emphasizing support for AI leadership and innovation. It mirrors Congressional interest in clarifying § 101 and could pave the way for more formal USPTO rulemaking or revised AI-specific guidance.

  • Practical Lessons for Practitioners

Applicants should frame AI inventions in terms of technical improvements, such as reduced computational load, enhanced accuracy, or resource efficiency, in a way which clearly ties the technical effect to the claim elements. Specifications should clearly set out how these improvements arise from the claimed features of the invention.

Conclusion: A Policy Recalibration?

Although limited in scope, the present decision signals a symbolic shift in USPTO policy. Director John Squires appears intent on softening the PTAB’s strict § 101 stance by affirming that AI inventions should be judged by their technical contributions, not dismissed as abstract. The Appeals Review Panel underscored this, warning that “excluding AI innovations from patent protection in the United States jeopardizes America’s leadership in this critical emerging technology” and clarifying that the key question is whether the invention achieves a specific technological improvement. This approach reflects a broader U.S. effort to support domestic AI innovation and keep patent policy aligned with global competitiveness.

For patent attorneys and innovators, this development offers cautious optimism. While Ex parte Desjardins will not rewrite § 101 overnight, it meaningfully reorients the USPTO’s stance toward AI in a manner not unlike the current EPO policy, recognizing that the challenge lies not in defining “abstract ideas,” but in protecting genuine technological advancement.


This article was prepared by Patent Attorney Romain Bouchand and Senior Patent Attorney Joe Baumber.

Latest updates

Event - 4th November 2026

IAM Navigating the UPC conference

HGF are gold sponsors of the IAM Live Navigating the UPC conference. IAM Live: Navigating the UPC returns to Paris in November bringing together over 180 industry leaders for an …

Event details
Event - 12th October 2026

HGF to attend Festival of Biologics 2026

HGF is pleased to announce that Frédéric Didelon, Partner and European Patent Attorney in our Life Sciences team, will be attending the Festival of Biologics, taking place 13-15 October 2026 …

Event details
Event - 29th October 2026

Join us for HGF’s IP clinic after ETZ EnergyWorks' Brewed for Growth event

Following ETZ EnergyWorks’ Brewed for Growth event on Thursday 29 October, we are hosting our next IP clinic from 10am-1pm, offering practical, confidential advice at no cost. If you’re developing …

Event details
Event - 27th October 2026

HGF sponsors pro-manchester Retail Lunch 2026

HGF is delighted to be sponsoring pro-manchester Retail Lunch 2026, taking place on Tuesday 27 October 2026 at INNSiDE by Meliá in Manchester. As part of the event, HGF Partner …

Event details
Event - 7th - 10th October 2026

HGF Attending AIPPI World Congress 2026

HGF is attending the AIPPI World Congress 2026, taking place in Hamburg from 7-10 October 2026. Bringing together intellectual property professionals from around the world, the annual Congress is one …

Event details
Event - 12th November 2026

HGF to Host Bionow Biotech & Beers Networking Event in Leeds

HGF is pleased to be partnering with Bionow to host the next Biotech & Beers networking event in Leeds on 12 November 2026, bringing together professionals from across the life …

Event details
Event - 18th November 2026

HGF Venture: Funding the Future

Join fellow life sciences founders, investors and business leaders for an evening of drinks and networking in Cambridge on the 18th November, 5-9pm. Featuring an investor-founder round table and an …

Event details
Event - 22nd September 2026

HGF are sponsors of LSPN Europe 2026

HGF is proud to sponsor LSPN Europe 2026, the premier event for IP professionals in the life sciences sector. Join us on September 22-23 in Basel for two days packed …

Event details